Abstract 2046P
Background
Effective communication between doctors and patients is crucial, especially when delivering bad news that can impact a person's present and future expectations. However, acquiring optimal skills in breaking bad news requires the incorporation of multiple professional competencies that are acquired gradually through years of training. The purpose of this study was to conduct a systematic review of existing literature on medical education programs and interventions aiming to improve communication skills and to critically evaluate the effectiveness of such training.
Methods
We conducted a systematic review following PRISMA guidelines, searching PubMed and Scopus databases at February 2023, using the key words “medical education,” “breaking bad news,” and “end of life communication.”
Results
Our search yielded 21 relevant studies, with 12 randomized studies indicating improvements in trainees found in PubMed, while four Scopus studies referred to workshops and seminars that increased participants' confidence in various communication areas. Furthermore, eight studies referred to training courses on communication techniques that helped medical students and health professionals develop confidence in breaking bad news skills. One study utilized interactive theater and role-play with professional actors to teach breaking bad news to medical students, which can be a potentially powerful tool for teaching breaking bad news during medical education. One study showed that the COVID-19 pandemic has disrupted health education due to social distancing.
Conclusions
Our findings suggest that training physicians at the undergraduate and postgraduate levels in communication skills for breaking bad news can be beneficial for both physicians and patients. However, limitations exist in reaching definitive conclusions. As digital learning has emerged in healthcare education during the post-COVID-19 period, digital solutions have also been examined for training in the communication of bad news.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2028TiP - Phase I, non-randomised, open-label, multi-centre dose escalation trial of BI 764532 (DLL3/CD3 IgG-like T cell engager [TcE]) + ezabenlimab (anti-PD-1 antibody) in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs) expressing DLL3
Presenter: Julien Mazieres
Session: Poster session 06
2029TiP - Phase I study of ABBV-706, an anti-SEZ6 antibody-drug conjugate, alone or in combination in adults with advanced solid tumors
Presenter: Sreenivasa Chandana
Session: Poster session 06
2035P - Routine biomarker monitoring does not replace comprehensive clinical assessment in the detection of immunotherapy induced myocarditis
Presenter: Alexandra Johnson
Session: Poster session 06
2036P - Prevalence and risk evaluation of cardiovascular disease among newly diagnosed prostate cancer population in China
Presenter: Weiyu Zhang
Session: Poster session 06
2037P - Prehabilitation as a strategy to improve postoperative outcomes in frail cancer patients undergoing elective surgery: A systematic review and meta-analysis
Presenter: Muhammed Elfaituri
Session: Poster session 06
2039P - Primary endpoints of confirmatory randomized controlled trials for older patients with cancer: A scoping review
Presenter: Tomonori Mizutani
Session: Poster session 06
2041P - The prevalence of hematologic adverse events (HAEs) and myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) in patients (pts) with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitor (PARPi), with or without a germline BRCA pathogenic variant
Presenter: Carmine Valenza
Session: Poster session 06
2042P - Improving breast cancer outcomes for indigenous women
Presenter: Vita Christie
Session: Poster session 06
2043P - Can Charlson Comorbidity Index (CCI) and Clinical Frailty Scale (CFS) assessments predict survival in octogenarians with colorectal cancer?
Presenter: Neda Nikolic
Session: Poster session 06
2044P - Bloodstream infections (BSI) in cancer patients: Epidemiology, antibiotic therapy and risk factors related to mortality
Presenter: Carlos López Jiménez
Session: Poster session 06